PG
CVX icon

Prostatis Group’s Chevron CVX Stock Holding History

Prostatis Group’s Portfolio CVX Stock Details CVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$911K Buy
5,495
+2,069
+60% +$385K 0.21% 79
2026
Q1 		$709K Sell
3,426
-703
-17% -$128K 0.18% 89
2025
Q4 		$629K Buy
4,129
+1,017
+33% +$155K 0.15% 92
2025
Q3 		$483K Sell
3,112
-164
-5% -$25.4K 0.12% 98
2025
Q2 		$469K Sell
3,276
-387
-11% -$54.6K 0.13% 99
2025
Q1 		$613K Sell
3,663
-133
-4% -$20.8K 0.19% 86
2024
Q4 		$550K Sell
3,796
-330
-8% -$50.5K 0.16% 102
2024
Q3 		$608K Sell
4,126
-6,846
-62% -$1.02M 0.2% 83
2024
Q2 		$1.73M Sell
10,972
-66
-0.6% -$10.5K 0.61% 47
2024
Q1 		$1.73M Buy
11,038
+1,437
+15% +$217K 0.66% 45
2023
Q4 		$1.43M Buy
9,601
+26
+0.3% +$3.93K 0.6% 44
2023
Q3 		$1.63M Buy
9,575
+2,270
+31% +$367K 0.8% 30
2023
Q2 		$1.15M Sell
7,305
-429
-6% -$68.8K 0.53% 44
2023
Q1 		$1.26M Sell
7,734
-168
-2% -$28.2K 0.66% 37
2022
Q4 		$1.42M Buy
+7,902
New +$1.38M 0.87% 31
2022
Q2 		– Sell
-6,500
Closed -$1.06M – 53
2022
Q1 		$1.06M Buy
+6,500
New +$932K 0.85% 34

Other funds holding CVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Prostatis Group's CVX Position: Q2 2026 in Review

Prostatis Group increased its Chevron (CVX) stake by 60% in Q2 2026, buying an estimated $385K and bringing the position to 5,495 shares worth $911K. The position accounts for 0.21% of the portfolio, ranked #79.

Prostatis Group first reported a position in CVX in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.73M in Q1 2024. 4,141 funds tracked by Wall St. Rank hold CVX as of Q2 2026.

  • Prostatis Group held 5,495 shares of Chevron worth $911K as of Q2 2026.
  • Prostatis Group bought 2,069 Chevron shares in Q2 2026, an estimated $385K.
  • Chevron made up 0.21% of Prostatis Group's portfolio in Q2 2026, its #79 holding.
  • Prostatis Group first reported a position in Chevron in Q1 2022 and has held it in 16 quarters since.
  • Prostatis Group's Chevron position peaked at $1.73M in Q1 2024.
  • 4,141 funds tracked by Wall St. Rank held Chevron as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.